Results 51 to 60 of about 16,908 (210)

Estudio comparativo en el manejo médico del aborto terapéutico entre el uso de mifepristone más misoprostol y el uso de misoprostol solo

Revista Peruana de Investigación Materno Perinatal, 2019
Objetivos: Evaluar las diferencias en el manejo médico del aborto terapéutico usando Mifepristone más Misoprostol comparado con el uso de Misoprostol solo.
Enrique Guevara-Ríos, Antonio Luna-Figueroa, Miguel Gutiérrez-Ramos, Félix Dasio Ayala-Peralta, Cesar Carranza-Asmat, Pedro Arango-Ochante, Marcos Espinola-Sánchez, Percy Minaya-León, Pedro Mascaro-Sánchez, Juan Díaz-Villar, Felipe Loo-Choy, Luis Kobayashi-Tsutsumi, Dennys Celedonio-Salvador, Luis Almeyda-Castro, Jhony Juarez-Montalvan, Leonardo Lachira-León, Luis Makiya-Onaga, Fredy Jesús Cabrera-Olórtegui, Melisa Mejico Caja, Augusto Racchumí-Vela   +19 more
doaj   +1 more source

Posttraumatic stress disorder 2 months after induced vaginal delivery: A multicenter prospective study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objectives An increased risk of postpartum posttraumatic stress disorder (PTSD) has been reported in women who had labor induced. Knowledge of childbirth‐related PTSD in this context remain poorly documented. Our aim was to assess the PTSD prevalence and identify characteristics associated with it after induced vaginal delivery at or near term.
Alizée Froeliger, Catherine Deneux‐Tharaux, Lola Loussert, Anne Laure Sutter‐Dallay, Hugo Madar, Loïc Sentilhes, on behalf of the Tranexamic Acid for Preventing Postpartum Hemorrhage Following a Vaginal Delivery (TRAAP) study group, Loïc Sentilhes, Norbert Winer, Elie Azria, Marie Victoire Sénat, Camille Le Ray, Delphine Vardon, Franck Perrotin, Raoul Desbrière, Florent Fuchs, Gilles Kayem, Guillaume Ducarme, Muriel Doret‐Dion, Cyril Huissoud, Caroline Bohec, Philippe Deruelle, Astrid Darsonval, Jean‐Marie Chrétien, Aurélien Seco, Valérie Daniel, Catherine Deneux‐Tharaux   +26 more
wiley   +1 more source

Comparison of the Efficacy of Vaginal Misoprostol with and without Laminaria in Second Trimester Induction Abortion [PDF]

Journal of Kerman University of Medical Sciences, 2012
Background & Aims: Therapeutic abortion in the second trimester pregnancy is the choice treatment in cases with severe anomalies or intrauterine fetal death. It can be done by a number of medical (e.g. misoprostol) or mechanical methods (e.g. laminaria).
Z Salari, L SHarifi, B.SH Aali
doaj  

Mifepristone and misoprostol versus placebo and misoprostol for resolution of miscarriage in women diagnosed with missed miscarriage: the MifeMiso RCT

Health Technology Assessment, 2021
Trial design: A randomised, parallel-group, double-blind, placebo-controlled multicentre study with health economic and nested qualitative studies to determine if mifepristone (Mifegyne®, Exelgyn, Paris, France) plus misoprostol is superior to ...
Adam Devall, Justin Chu, Leanne Beeson, Pollyanna Hardy, Versha Cheed, Yongzhong Sun, Tracy Roberts, Chidubem Okeke Ogwulu, Eleanor Williams, Laura Jones, Jenny La Fontaine Papadopoulos, Ruth Bender-Atik, Jane Brewin, Kim Hinshaw, Meenakshi Choudhary, Amna Ahmed, Joel Naftalin, Natalie Nunes, Abigail Oliver, Feras Izzat, Kalsang Bhatia, Ismail Hassan, Yadava Jeve, Judith Hamilton, Shilpa Deb, Cecilia Bottomley, Jackie Ross, Linda Watkins, Martyn Underwood, Ying Cheong, Chitra Kumar, Pratima Gupta, Rachel Small, Stewart Pringle, Frances Hodge, Anupama Shahid, Ioannis Gallos, Andrew Horne, Siobhan Quenby, Arri Coomarasamy   +39 more
doaj   +1 more source

Misoprostol with or without letrozole pretreatment for termination of pregnancy: A randomized controlled trial

, 2011
Objective: To compare the success rate and side effects of letrozole and misoprostol versus misoprostol alone for medical termination of early pregnancy.
Ho, PC, Lee, VCY, Ng, EHY, Yeung, WSB
core   +1 more source

Rectal vs. sublingual misoprostol in cesarean section: three‑arm, randomized clinical trial

Caspian Journal of Internal Medicine, 2022
Background: Misoprostol is a myometrial stimulant with uterotonic properties and can be administered rectally, vaginally, or sublingually. Numerous studies have investigated the effect of misoprostol on the prevention and treatment of PPH (postpartum ...
Fatemeh Zahra Bagheri, Mahboobeh Azadehrah, Bizhan Shabankhani, Hooshang Akbari, Ebrahim Nasiri Ferami   +4 more
doaj  

Is the Time of administration of misoprostol of value? The uterotonic effect of misoprostol given pre- and post-operative after elective cesarean section

Middle East Fertility Society Journal, 2014
Objective: The aim of the current study was to compare blood loss in pre- and post-operatively rectally administered 600 μg of misoprostol in elective cesarean delivery, in order to determine the optimal time for drug administration (CS). Study design: A
Ahmed H. Abd-Ellah, Abdel Aziz E. Tamam, Mostafa Mohammed Khodry   +2 more
doaj   +1 more source

Therapeutic orphans no more: Revisiting the ethical justification for excluding pregnant women from pharmaceutical clinical trials

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract For six decades, pregnant women have been routinely excluded from pharmaceutical clinical trials, a practice rooted in a protectionist ethic that emerged after the thalidomide tragedy. This narrative review examines whether that exclusion remains ethically justifiable, drawing on the obstetric, pharmacological, and bioethical literature ...
Camila Kruger Cabar, Fábio Roberto Cabar   +1 more
wiley   +1 more source

Acceptability of misoprostol-only medication abortion dispensed by mail-order or retail pharmacy: a qualitative study based on in-depth interviews in the United States

Sexual and Reproductive Health Matters
The WHO recommends two medication abortion regimens, either misoprostol used with mifepristone or misoprostol-only. Both regimens are recognised as safe and effective, but in the United States (US) most abortions are completed using mifepristone and ...
Dana M. Johnson, Sruthi Ramaswamy, Rebecca Gomperts   +2 more
doaj   +1 more source

Recombinant activated factor VIIa for severe postpartum hemorrhage in Africa: Evidence, appropriate use, and research priorities—A narrative review

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Postpartum hemorrhage (PPH) accounts for 30%–50% of maternal mortality in Africa and occurs in the context of pre‐existing anemia, limited blood product availability, delayed recognition, and constrained referral systems. Although bundle‐based care (E‐MOTIVE), early tranexamic acid (TXA), and uterotonics have substantially improved outcomes, a
Johnny Mahlangu, Haroun Rhemtula, Jarrod Zamparini, Lawrence Chauke   +3 more
wiley   +1 more source